Jeffrey Boone Miller, PhD

Professor, Neurology

Jeffrey Miller
(617) 638-5355
700 Albany St Ctr for Adv Biomed Res

Other Positions

  • Professor, Physiology & Biophysics, Boston University School of Medicine

Education

  • University of California, Berkeley, PhD
  • Washington State University, BS

Publications

  • Published on 12/1/2016

    Homma S, Beermann ML, Yu B, Boyce FM, Miller JB. Nuclear bodies reorganize during myogenesis in vitro and are differentially disrupted by expression of FSHD-associated DUX4. Skelet Muscle. 2016 Dec 01; 6(1):42. PMID: 27906075.

    Read at: PubMed
  • Published on 3/29/2015

    Jones TI, King OD, Himeda CL, Homma S, Chen JC, Beermann ML, Yan C, Emerson CP, Miller JB, Wagner KR, Jones PL. Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy. Clin Epigenetics. 2015; 7(1):37. PMID: 25904990.

    Read at: PubMed
  • Published on 1/15/2015

    Homma S, Beermann ML, Boyce FM, Miller JB. Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation. Ann Clin Transl Neurol. 2015 Feb; 2(2):151-66. PMID: 25750920.

    Read at: PubMed
  • Published on 3/17/2014

    Himeda CL, Debarnot C, Homma S, Beermann ML, Miller JB, Jones PL, Jones TI. Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene. Mol Cell Biol. 2014 Jun; 34(11):1942-55. PMID: 24636994.

    Read at: PubMed
  • Published on 12/6/2013

    Yoon S, Stadler G, Beermann ML, Schmidt EV, Windelborn JA, Schneiderat P, Wright WE, Miller JB. Immortalized myogenic cells from congenital muscular dystrophy type1A patients recapitulate aberrant caspase activation in pathogenesis: a new tool for MDC1A research. Skelet Muscle. 2013; 3(1):28. PMID: 24314268.

    Read at: PubMed
  • Published on 7/13/2012

    Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP, Wagner KR, Jones PL. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet. 2012 Oct 15; 21(20):4419-30. PMID: 22798623.

    Read at: PubMed
  • Published on 11/23/2011

    Homma S, Chen JC, Rahimov F, Beermann ML, Hanger K, Bibat GM, Wagner KR, Kunkel LM, Emerson CP, Miller JB. A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function. Eur J Hum Genet. 2012 Apr; 20(4):404-10. PMID: 22108603.

    Read at: PubMed
  • Published on 4/19/2011

    Homma S, Beermann ML, Miller JB. Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-a2-deficient mouse model of congenital muscular dystrophy. Hum Mol Genet. 2011 Jul 1; 20(13):2662-72. PMID: 21505075.

    Read at: PubMed
  • Published on 1/1/2011

    Homma S, Beermann ML, Miller JB. Assessment of peripheral nerve pathology in laminin-alpha2-deficient mice. European Neuromuscular Network. Newcastle-upon-Tyne, United Kingdom. 2011.

    Read at: Custom
  • Published on 4/1/2010

    Beermann ML, Ardelt M, Girgenrath M, Miller JB. Prdm1 (Blimp-1) and the expression of fast and slow myosin heavy chain isoforms during avian myogenesis in vitro. PLoS One. 2010; 5(4):e9951. PMID: 20376350.

    Read at: PubMed

View 68 more publications: View full profile at BUMC

View all profiles